Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.73

+0.50 (0.82%)

as of Aug 14, 2026, 8:00:00 pm Market Open.

1631 watching

Investor Insights

Aug 14, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has shown a solid performance in recent quarters, buoyed by its strong presence in Asia and effective wealth management strategies. However, there are concerns regarding its valuation, as it is perceived to be somewhat overbought, trading over 2x book value with limited earnings growth expected in the near future. Despite these concerns, many experts highlight its decent dividend yield and ongoing growth potential, particularly in its Asian markets. The recent implementation of a tax on MFC products for mainland Chinese residents adds a layer of uncertainty. Overall, the sentiment among analysts is cautiously optimistic, with a call for careful monitoring of market conditions and potential entry points for investment.

Consensus

Cautious

Valuation

Fair Value

Similar

GWO

DON'T BUY

Large surprise equity issue recently, which has not been cleared yet, which is why the share price is trading under the issue price. Lifecos in Canada are going to be in a pretty tight trading range until there is some clarity on the new regulations.

Wealthica Track your Stocks in your Watch List

COMMENT

Feels there is valuation support at these levels.

DON'T BUY

Not a big fan of this. Likes companies that do well in a tough environment and will do well going forward. Due to product mixes they were in a tough spot. Economy has challenges ahead and this would be one of the first that has to come back to the market again.

TOP PICK

If you are coming into it now, the balance sheet is that much better. Now they can go on and make acquisitions. They are one of the leaders in Asia. Cleaned up their balance sheet. They are still getting priced at levels that are somewhat irrational. Expects 30% return over the next two years.

DON'T BUY

Announcement of the new equity issue caught everybody by surprise and he thinks they will have a tough slog and they may have to reduce the price to get rid of the shares. Thinks the stock will be a dead issue for a while. Longer-term they have good assets. Prefers the banks.

HOLD

Announced a $2.5 billion share issue, which caught everybody by surprise. Hopes that they will use this for good acquisitions. Fundamentally it is worth more than $19 a share and expects it to trend upwards.

WATCH

Prefers Great West (GWO-T) because of their yield. This one and Sun Life (SLF-T) are more levered to the stock market. Likes their growth opportunities in China once they get their new team in place. They cut the dividend and are still smarting from this.

BUY

3rd quarter had a lot of charges and write-downs but the earnings power is still there.

COMMENT

Stock has broken below what should have been its support. If you own, use a $19 stoploss because if that amount triggers you are looking at $12 again.

COMMENT

Bought half a position. A “show me” story. He will watch, look at the earnings and if it appeals to him he will add to his position otherwise will sell.

DON'T BUY

$26 stock price is not too far-fetched if we get the US consumer coming back and there is economic growth in the developed world and there is continued recovery. Extremely exposed to what happens in the equity markets.

PARTIAL SELL

Problem with the lifecos in that they have a fair amount of business being done in the equity market through mutual fund sales. If equity markets come under pressure this will hit their earnings. He is lessening his holdings.

BUY

Lifecos are down basically because the market is down because of credit and stock market concerns. If you have any kind of time horizon you can't go wrong.

DON'T BUY

Wants to talk people out of the insurance sector. Would rather be in bank stocks.

DON'T BUY

This is a leveraged call on the stock market. If you are bullish on the stock market, you can stick with this one. If you are concerned, as he is, then you shouldn't go into this. Just a little bit shy of its Fair Market Value.

Showing 1,561 to 1,575 of 2,284 entries

Most Recent Experts

Bill Baruch, Founder, Blue Line Capital

Blue Line Capital

Richard Orrell

RN Croft Financial Group

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)